Karly A Stanley

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Breast Cancer Cells

Multidrug Resistant

Binding Protein

Dna Methylation

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah C Wistner, Ian A MacDonald, Karly A Stanley, Nathaniel A Hathaway
Characterization of Hepatoma-Derived Growth Factor-Related Protein 2 Interactions with Heterochromatin. Cells 12 (2) (2023)
Sarah C Wistner, Ian A MacDonald, Karly A Stanley, Nathaniel A Hathaway
Characterization of Hepatoma-Derived Growth Factor-Related Protein 2 Interactions with Heterochromatin. Cells 12 (2) (2023)
Sarah C Wistner, Ian A MacDonald, Karly A Stanley, Nathaniel A Hathaway
Characterization of Hepatoma-Derived Growth Factor-Related Protein 2 Interactions with Heterochromatin. Cells 12 (2) (2023)
Sarah C Wistner, Ian A MacDonald, Karly A Stanley, Nathaniel A Hathaway
Characterization of Hepatoma-Derived Growth Factor-Related Protein 2 Interactions with Heterochromatin. Cells 12 (2) (2023)
Gennie L Parkman, Tursun Turapov, David A Kircher, William J Burnett, Christopher M Stehn, Kayla O'Toole, Katie M Culver, Ashley T Chadwick, Riley C Elmer, Ryan Flaherty, Karly A Stanley, Mona Foth, David H Lum, Robert L Judson, John E Friend, Matthew W VanBrocklin, Martin McMahon, Sheri L Holmen
Genetic silencing of AKT induces melanoma cell death via mTOR suppression. Molecular cancer therapeutics (2023)